The gender specificity of P2X7 receptor is also previously investigated in amyotrophic lateral sclerosis mice model in which different P2X7 receptor antagonists show better efficacy in attenuating disease progression in one sex than the other [56, 57]. Here, P2RX7 is linked to amyotrophic lateral sclerosis.